![Johan Lannebo](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Perfil
Johan Lannebo is the founder of Lannebo Fonder AB, a company he founded in 2000 where he currently serves as Fund Manager & Chairman of the Board.
He also worked as a Director at Recipharm AB in the past.
Cargos activos de Johan Lannebo
Empresas | Cargo | Inicio |
---|---|---|
Lannebo Fonder AB
![]() Lannebo Fonder AB Investment ManagersFinance Lannebo Fonder AB (Lannebo) is an independent fund management firm headquartered in Stockholm, Sweden. The firm was founded in 2000 by Anders Lannebo together with a group of portfolio managers from fund management companies of Nordic banks. Lannebo manages a range of Swedish mutual funds for individuals and institutional clients. Lannebo Fonder is a socially responsible investor and a signatory to the United Nations-supported Principles for Responsible Investment (UNPRI). | Fundador | 01/01/2000 |
Antiguos cargos conocidos de Johan Lannebo.
Empresas | Cargo | Fin |
---|---|---|
RECIPHARM AB (PUBL) | Director/Miembro de la Junta | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Lannebo Fonder AB
![]() Lannebo Fonder AB Investment ManagersFinance Lannebo Fonder AB (Lannebo) is an independent fund management firm headquartered in Stockholm, Sweden. The firm was founded in 2000 by Anders Lannebo together with a group of portfolio managers from fund management companies of Nordic banks. Lannebo manages a range of Swedish mutual funds for individuals and institutional clients. Lannebo Fonder is a socially responsible investor and a signatory to the United Nations-supported Principles for Responsible Investment (UNPRI). | Finance |
Recipharm AB
![]() Recipharm AB BiotechnologyHealth Technology Recipharm AB engages in the manufacture of pharmaceuticals and contract development services for pharmaceutical companies. It operates through the following segments: Manufacturing Sterile and Inhalation (MFG-SI); Manufacturing Solids and Others (MFG-SO); Development and Technology (D&T); and Others and Eliminations. The MFG-SI segment includes manufacturing of products on behalf of pharmaceutical companies and covers sterile and inhalation technologies as well as liquid vials and ampoules, lyophilisates, blow-fill-seal products, and inhalation. The MFG-SO segment produces products on behalf of pharmaceutical companies and covers tablets, capsules, semi-solids, and non-sterile liquids. The D&T segment focuses on pharmaceutical development services. The company was founded by Lars Rickard Backsell and Thomas Bengt Eldered in 1995 and is headquartered in Stockholm, Sweden. | Health Technology |
- Bolsa de valores
- Insiders
- Johan Lannebo